Finally, similar significant increases in cytotoxic T cells were obtained in the tumor implantation and early growth TBR5 model at sacrifice 2 weeks after exogenous NF-κB stimulation, again demonstrating that the increases in anti-tumor immunity in IKFM mice were persistent (Fig. 5e-h). The gene discussed is NFKB1; the disease is neoplasm.